Selected research
Market Outlook & Growth Opportunities
Global Chatbots for Mental Health and Therapy Market Outlook and Growth Opportunities 2026
Market perspective
The global Chatbots for Mental Health and Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Chatbots for Mental Health and Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Chatbots for Mental Health and Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Chatbots for Mental Health and Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Chatbots for Mental Health and Therapy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Chatbots for Mental Health and Therapy market include Wysa Ltd, Ginger, Woebot Health, Marigold Health, Bark Technologies, Mindstrong Health, BioBeats, Lyra Health and Cognoa, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Chatbots for Mental Health and Therapy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Chatbots for Mental Health and Therapy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Chatbots for Mental Health and Therapy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Chatbots for Mental Health and Therapy market.
Chatbots for Mental Health and Therapy Segment by Company
Wysa Ltd
Ginger
Woebot Health
Marigold Health
Bark Technologies
Mindstrong Health
BioBeats
Lyra Health
Cognoa
MeQuilibrium
Chatbots for Mental Health and Therapy Segment by Type
Machine Learning and Deep Learning
Natural Language Processing
Others
Chatbots for Mental Health and Therapy Segment by Application
Conversational Interfaces
Behavioral Pattern Recognition
Others
Chatbots for Mental Health and Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Chatbots for Mental Health and Therapy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Chatbots for Mental Health and Therapy key companies, revenue, market share, and recent developments.
3. To split the Chatbots for Mental Health and Therapy breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Chatbots for Mental Health and Therapy market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Chatbots for Mental Health and Therapy significant trends, drivers, influence factors in global and regions.
6. To analyze Chatbots for Mental Health and Therapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chatbots for Mental Health and Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chatbots for Mental Health and Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chatbots for Mental Health and Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chatbots for Mental Health and Therapy industry.
Chapter 3: Detailed analysis of Chatbots for Mental Health and Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Chatbots for Mental Health and Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Chatbots for Mental Health and Therapy in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Machine Learning and Deep Learning
- Natural Language Processing
- Others
Applications
- Conversational Interfaces
- Behavioral Pattern Recognition
- Others
Companies covered
- Wysa Ltd
- Ginger
- Woebot Health
- Marigold Health
- Bark Technologies
- Mindstrong Health
- BioBeats
- Lyra Health
- Cognoa
- MeQuilibrium
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Chatbots for Mental Health and Therapy Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Chatbots for Mental Health and Therapy Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Chatbots for Mental Health and Therapy Market Dynamics
- 2.1 Chatbots for Mental Health and Therapy Industry Trends
- 2.2 Chatbots for Mental Health and Therapy Industry Drivers
- 2.3 Chatbots for Mental Health and Therapy Industry Opportunities and Challenges
- 2.4 Chatbots for Mental Health and Therapy Industry Restraints
3 Chatbots for Mental Health and Therapy Market by Company
- 3.1 Global Chatbots for Mental Health and Therapy Company Revenue Ranking in 2025
- 3.2 Global Chatbots for Mental Health and Therapy Revenue by Company (2021-2026)
- 3.3 Global Chatbots for Mental Health and Therapy Company Ranking (2024-2026)
- 3.4 Global Chatbots for Mental Health and Therapy Company Manufacturing Base and Headquarters
- 3.5 Global Chatbots for Mental Health and Therapy Company Product Type and Application
- 3.6 Global Chatbots for Mental Health and Therapy Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Chatbots for Mental Health and Therapy Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Chatbots for Mental Health and Therapy Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Chatbots for Mental Health and Therapy Market by Type
- 4.1 Chatbots for Mental Health and Therapy Type Introduction
- 4.1.1 Machine Learning and Deep Learning
- 4.1.2 Natural Language Processing
- 4.1.3 Others
- 4.2 Global Chatbots for Mental Health and Therapy Sales Value by Type
- 4.2.1 Global Chatbots for Mental Health and Therapy Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Chatbots for Mental Health and Therapy Sales Value by Type (2021-2032)
- 4.2.3 Global Chatbots for Mental Health and Therapy Sales Value Share by Type (2021-2032)
5 Chatbots for Mental Health and Therapy Market by Application
- 5.1 Chatbots for Mental Health and Therapy Application Introduction
- 5.1.1 Conversational Interfaces
- 5.1.2 Behavioral Pattern Recognition
- 5.1.3 Others
- 5.2 Global Chatbots for Mental Health and Therapy Sales Value by Application
- 5.2.1 Global Chatbots for Mental Health and Therapy Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Chatbots for Mental Health and Therapy Sales Value by Application (2021-2032)
- 5.2.3 Global Chatbots for Mental Health and Therapy Sales Value Share by Application (2021-2032)
6 Chatbots for Mental Health and Therapy Regional Value Analysis
- 6.1 Global Chatbots for Mental Health and Therapy Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Chatbots for Mental Health and Therapy Sales Value by Region (2021-2032)
- 6.2.1 Global Chatbots for Mental Health and Therapy Sales Value by Region: 2021-2026
- 6.2.2 Global Chatbots for Mental Health and Therapy Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Chatbots for Mental Health and Therapy Sales Value (2021-2032)
- 6.3.2 North America Chatbots for Mental Health and Therapy Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Chatbots for Mental Health and Therapy Sales Value (2021-2032)
- 6.4.2 Europe Chatbots for Mental Health and Therapy Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Chatbots for Mental Health and Therapy Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Chatbots for Mental Health and Therapy Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Chatbots for Mental Health and Therapy Sales Value (2021-2032)
- 6.6.2 South America Chatbots for Mental Health and Therapy Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Chatbots for Mental Health and Therapy Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Chatbots for Mental Health and Therapy Sales Value Share by Country, 2025 VS 2032
7 Chatbots for Mental Health and Therapy Country-level Value Analysis
- 7.1 Global Chatbots for Mental Health and Therapy Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Chatbots for Mental Health and Therapy Sales Value by Country (2021-2032)
- 7.2.1 Global Chatbots for Mental Health and Therapy Sales Value by Country (2021-2026)
- 7.2.2 Global Chatbots for Mental Health and Therapy Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.7.2 France Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.14.2 China Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.17.2 India Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Chatbots for Mental Health and Therapy Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Chatbots for Mental Health and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Chatbots for Mental Health and Therapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Wysa Ltd
- 8.1.1 Wysa Ltd Company Information
- 8.1.2 Wysa Ltd Business Overview
- 8.1.3 Wysa Ltd Chatbots for Mental Health and Therapy Revenue and Gross Margin (2021-2026)
- 8.1.4 Wysa Ltd Chatbots for Mental Health and Therapy Product Portfolio
- 8.1.5 Wysa Ltd Recent Developments
- 8.2 Ginger
- 8.2.1 Ginger Company Information
- 8.2.2 Ginger Business Overview
- 8.2.3 Ginger Chatbots for Mental Health and Therapy Revenue and Gross Margin (2021-2026)
- 8.2.4 Ginger Chatbots for Mental Health and Therapy Product Portfolio
- 8.2.5 Ginger Recent Developments
- 8.3 Woebot Health
- 8.3.1 Woebot Health Company Information
- 8.3.2 Woebot Health Business Overview
- 8.3.3 Woebot Health Chatbots for Mental Health and Therapy Revenue and Gross Margin (2021-2026)
- 8.3.4 Woebot Health Chatbots for Mental Health and Therapy Product Portfolio
- 8.3.5 Woebot Health Recent Developments
- 8.4 Marigold Health
- 8.4.1 Marigold Health Company Information
- 8.4.2 Marigold Health Business Overview
- 8.4.3 Marigold Health Chatbots for Mental Health and Therapy Revenue and Gross Margin (2021-2026)
- 8.4.4 Marigold Health Chatbots for Mental Health and Therapy Product Portfolio
- 8.4.5 Marigold Health Recent Developments
- 8.5 Bark Technologies
- 8.5.1 Bark Technologies Company Information
- 8.5.2 Bark Technologies Business Overview
- 8.5.3 Bark Technologies Chatbots for Mental Health and Therapy Revenue and Gross Margin (2021-2026)
- 8.5.4 Bark Technologies Chatbots for Mental Health and Therapy Product Portfolio
- 8.5.5 Bark Technologies Recent Developments
- 8.6 Mindstrong Health
- 8.6.1 Mindstrong Health Company Information
- 8.6.2 Mindstrong Health Business Overview
- 8.6.3 Mindstrong Health Chatbots for Mental Health and Therapy Revenue and Gross Margin (2021-2026)
- 8.6.4 Mindstrong Health Chatbots for Mental Health and Therapy Product Portfolio
- 8.6.5 Mindstrong Health Recent Developments
- 8.7 BioBeats
- 8.7.1 BioBeats Company Information
- 8.7.2 BioBeats Business Overview
- 8.7.3 BioBeats Chatbots for Mental Health and Therapy Revenue and Gross Margin (2021-2026)
- 8.7.4 BioBeats Chatbots for Mental Health and Therapy Product Portfolio
- 8.7.5 BioBeats Recent Developments
- 8.8 Lyra Health
- 8.8.1 Lyra Health Company Information
- 8.8.2 Lyra Health Business Overview
- 8.8.3 Lyra Health Chatbots for Mental Health and Therapy Revenue and Gross Margin (2021-2026)
- 8.8.4 Lyra Health Chatbots for Mental Health and Therapy Product Portfolio
- 8.8.5 Lyra Health Recent Developments
- 8.9 Cognoa
- 8.9.1 Cognoa Company Information
- 8.9.2 Cognoa Business Overview
- 8.9.3 Cognoa Chatbots for Mental Health and Therapy Revenue and Gross Margin (2021-2026)
- 8.9.4 Cognoa Chatbots for Mental Health and Therapy Product Portfolio
- 8.9.5 Cognoa Recent Developments
- 8.10 MeQuilibrium
- 8.10.1 MeQuilibrium Company Information
- 8.10.2 MeQuilibrium Business Overview
- 8.10.3 MeQuilibrium Chatbots for Mental Health and Therapy Revenue and Gross Margin (2021-2026)
- 8.10.4 MeQuilibrium Chatbots for Mental Health and Therapy Product Portfolio
- 8.10.5 MeQuilibrium Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst